Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2021 (LINC02021)

Target
LINC02021
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 2021 (LINC02021, also known as LOC124906285) is classified as a long intergenic non-coding RNA (lincRNA), which are autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes. LincRNAs are a subclass of long non-coding RNAs and are involved in a variety of mechanisms regulating gene expression, often with tissue specificity, including chromatin remodeling, acting as scaffolds for protein complexes, and contributing to transcriptional regulation. The overwhelming majority of lincRNAs, including LINC02021, have not been functionally annotated or associated with any specific biological pathways, disease mechanisms, or therapeutic targeting; only a small subset of lincRNAs have experimentally confirmed functions or disease associations. There is no evidence that LINC02021 functions as a receptor, enzyme, or other conventional therapeutic target. [1][5][7]

Other names
LOC124906285LINC02021
02

Mechanism of action

None established for drugs; general mechanisms for lincRNAs include serving as scaffolds for chromatin modifiers, acting as miRNA decoys, and influencing transcription

03

Biological functions

Regulation of chromatin structure and functionTranscriptional regulationRNA stabilizationFine-tuning expression of neighboring genes through various mechanismsChromatin remodeling (seen in general lincRNAs; not unique to LINC02021)
04

Disease associations

None specifically assigned to LINC02021 (general lincRNAs have roles in cancer, gene dosage, etc.)No disease association or therapeutic targeting information found for LINC02021 as of the current data
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2021 (LINC02021).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2021 (LINC02021).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call